Immunotherapy of brain metastases: breaking a “dogma”

Until very few years ago, the oncology community dogmatically excluded any clinical potential for immunotherapy in controlling brain metastases. Therefore, despite the significant therapeutic efficacy of monoclonal antibodies to immune check-point(s) across a wide range of tumor types, patients with...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Exp Clin Cancer Res
Hauptverfasser: Di Giacomo, Anna Maria, Valente, Monica, Cerase, Alfonso, Lofiego, Maria Fortunata, Piazzini, Francesca, Calabrò, Luana, Gambale, Elisabetta, Covre, Alessia, Maio, Michele
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2019
Schlagworte:
Review
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6798349/
https://ncbi.nlm.nih.gov/pubmed/31623643
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-019-1426-2
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge